CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
Mucopolysaccharidosis (MPS) syndromes are a group of heterogeneous genetic disorders in terms of genetic basis and clinical manifestations, ranging from mild to fatal forms. There are a number of applied or prospective treatment modalities for MPS, including bone marrow transplantation, enzyme repla...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2024-09-01
|
| Serija: | Biochemistry and Biophysics Reports |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S2405580824001353 |
| Oznake: |
Brez oznak, prvi označite!
|